Ultra-high single-dose radiation therapy for intermediate-risk prostate cancer is safe and associated with low toxicity. It offers tumor control and quality-of-life outcomes comparable to those of curative hypofractionated stereotactic body radiotherapy.

Ultra-high single-dose radiation therapy for intermediate-risk prostate cancer is safe and associated with low toxicity. It offers tumor control and quality-of-life outcomes comparable to those of curative hypofractionated stereotactic body radiotherapy.

https://www.renalandurologynews.com/home/news/urology/prostate-cancer/localized-prostate-cancer-ultra-high-single-dose-radiotherapy-vs-hypofractionated-sbrt/?utm_source=social&utm_medium=facebook&utm_content=a69fae13-2015-47f7-8904-a86bf31579d4&utm_campaign=run_daily_posts